Edition:
United Kingdom

ITUS Corp (ITUS.OQ)

ITUS.OQ on NASDAQ Stock Exchange Capital Market

2.69USD
15 Dec 2017
Change (% chg)

-- (--)
Prev Close
$2.69
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
296,570
52-wk High
$5.80
52-wk Low
$0.60

Chart for

About

ITUS Corporation is engaged in developing a diagnostic platform called Cchek, for the early detection of tumor-based cancers. The Cchek cancer detection platform measures a patient's immune response to a malignancy by detecting the presence, absence and quantity of certain immune cells that exist in and around a tumor and that... (more)
No analyst recommendations are available for .

Overall

Beta: -1.11
Market Cap(Mil.): $42.44
Shares Outstanding(Mil.): 15.32
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 26.72 16.44
EPS (TTM): -- -- --
ROI: -- 9.20 10.62
ROE: -- 12.34 14.20

BRIEF-Itus Corporation Terminates At-The-Market Offering

* ‍TERMINATED ITS AT-THE-MARKET EQUITY PROGRAM WITH B. RILEY FBR INC​ Source text for Eikon: Further company coverage:

12 Dec 2017

BRIEF-Itus enters into 2-year collaboration agreement

* Itus Corp - ‍on Nov 17, co, through unit entered into a 2 -year collaboration agreement with H. Lee Moffitt Cancer Center And Research Institute​

22 Nov 2017

BRIEF-ITUS Corp licenses CAR-T technology from Wistar Institute

* ITUS Corporation licenses CAR-T technology from the Wistar Institute

14 Nov 2017

BRIEF-ITUS Corp files for stock shelf offering of up to $24 mln

* ITUS Corp - files for stock shelf offering of up to $24 million - SEC filing‍​ Source text: (http://bit.ly/2yrgcTm) Further company coverage:

16 Oct 2017

BRIEF-Itus corp - ‍entered at-market issuance sales agreement with fbr capital to create equity program to sell up to $3.7 million common stock​

* Entered at-the-market issuance sales agreement with FBR capital to create equity program to sell up to $3.7 million common stock​ Source text for Eikon: Further company coverage:

29 Sep 2017

BRIEF-ITUS provides update on cancer detection technology and new CAR-T initiative for ovarian cancer

* ITUS provides update on cancer detection technology and new CAR-T initiative for ovarian cancer

21 Sep 2017

BRIEF-Itus Corporation announces issuance of patent on cancer detection technology

* Itus Corporation announces issuance of patent on cancer detection technology

18 Sep 2017

BRIEF-Itus Corp and Wistar Institute renew collaborative research agreement

* The Wistar Institute and Itus Corporation renew collaborative research agreement

07 Aug 2017

BRIEF-Itus Corp appoints Dr. Amit kumar as new CEO

* Itus appoints Dr. Amit Kumar as new CEO and announces management changes

07 Jul 2017

Earnings vs. Estimates

No consensus analysis data available.